Delivery Order SPE2DB22D3102-SPE2DB25FL2WH
Award Date 9/8/25
Potential Completion Date 9/9/25
Potential Value $1.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,120.08 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $1,444.42. This is a firm fixed-price delivery order with an ultimate completion date of August 4, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999.99 billion through December 2026. The contract contains no...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Naloxone Hydrochloride with a ceiling value of $4,330.94. This is a firm fixed-price, non-set-aside contract with a completion date of September 25, 2025, and will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Naloxone 0.4 mg/mL vials with a ceiling value of $5,434.06. The contract employs firm fixed-price pricing and is classified as a non-set-aside competitive award. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 22, 2025. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $1,169.75 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 ml syringes on August 18, 2025, with an ultimate completion date of August 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $7,550.56 by the Defense Logistics Agency's Medical Supply Chain on July 22, 2025, for the supply of Naloxone 1ML in quantities of 10 units. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 18, 2025. The contract will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at $999,999,999 and running through November 2026, enables the government to efficiently procure a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The specific delivery order,...
- The Defense Logistics Agency awarded a delivery order valued at $1,142.07 to AmerisourceBergen Drug Corp for the supply of Naloxone 2 mg/2 mL syringes on August 7, 2025, with an ultimate completion date of August 8, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Naloxone 4 mg/10 mL vials with a ceiling value of $11,898.39 and a firm fixed price structure. This is a competitively awarded, non-set-aside contract with an ultimate completion date of September 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Naloxone 0.4 mg/ml vials, with a contract ceiling value of $2,310.50. This firm fixed-price delivery order, awarded on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...